Zurzuvae | FDA approves first postpartum depression pill in the US
The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression.
Stay updated with breaking news from Fda Approves. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression.
The U.S. Food and Drug Administration approved Harm Reduction Therapeutics' RiVive, 3 milligram naloxone hydrochloride nasal spray for over-the-counter or OTC, nonprescription use for the emergency treatment of known or suspected opioid overdose.
Sanofi's RSV antibody shot, nirsevimab, got FDA approval to protect infants on Monday.
Sanofi's RSV antibody shot, nirsevimab, got FDA approval to protect infants on Monday.
The U.S. Food and Drug Administration approved Pfizer Inc's COVID-19 oral antiviral pill Paxlovid for the treatment of mild-to-moderate COVID-19 in adults. Paxlovid is the first oral treatment, and the fourth drug, approved by the agency to treat COVID-19 in adults.